Invasive prenatal testing in Hyderabad by OneDNA including karyotype analysis for detecting chromosomal abnormalities with expert care and precise results.
An invasive prenatal test is a diagnostic procedure performed during pregnancy to obtain fetal cells directly from the womb, providing definitive confirmation of genetic and chromosomal conditions rather than just risk estimation. Procedures such as Amniocentesis performed at 15–20 weeks and Chorionic villus sampling (CVS) performed at 13 weeks gestation.
Facing issue in account approval? email us at info@ipt.pw
FREE SEO TOOLS to Explore
Non-invasive prenatal testing in Hyderabad by OneDNA for early detection of fetal genetic conditions. Safe, accurate screening with highly reliable results.
Non-Invasive Prenatal Testing (NIPT, also called NIPS) is a genetic test performed during pregnancy to analyse tiny fragments of fetal DNA (called cell-free DNA) that circulate in the mother’s bloodstream. It helps detect numerical abnormalities responsible for conditions like Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13).
Non-Invasive Prenatal Testing (NIPT, also called NIPS) is a genetic test performed during pregnancy to analyse tiny fragments of fetal DNA (called cell-free DNA) that circulate in the mother’s bloodstream. It helps detect numerical abnormalities responsible for conditions like Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13).
Maternal serum screening by OneDNA helps assess risk of chromosomal abnormalities and neural tube defects during pregnancy with accurate and reliable results.
Maternal Serum Screening (MSS), often called the "Dual Screen" or "First Trimester Combined Screening," is a non-invasive prenatal test performed on a sample of the mother's blood. It analyses specific proteins and hormones produced by the placenta and fetus that can indicate an increased chance for certain chromosomal conditions and neural tube defects. It is important to understand: MSS is a screening test, not a diagnostic test. It
Maternal Serum Screening (MSS), often called the "Dual Screen" or "First Trimester Combined Screening," is a non-invasive prenatal test performed on a sample of the mother's blood. It analyses specific proteins and hormones produced by the placenta and fetus that can indicate an increased chance for certain chromosomal conditions and neural tube defects. It is important to understand: MSS is a screening test, not a diagnostic test. It
Carrier screening test by OneDNA helps identify inherited genetic risks before pregnancy, enabling informed family planning and reducing chances of passing conditions.
Carrier screening is a genetic test that identifies individuals who carry pathogenic variants associated with autosomal recessive disorders. Carriers are typically asymptomatic, as they possess one normal and one mutated allele. However, if both partners carry variants in the same gene, there is a 25% risk in each pregnancy of having an affected child, making carrier screening essential for accurate reproductive risk assessmen
Carrier screening is a genetic test that identifies individuals who carry pathogenic variants associated with autosomal recessive disorders. Carriers are typically asymptomatic, as they possess one normal and one mutated allele. However, if both partners carry variants in the same gene, there is a 25% risk in each pregnancy of having an affected child, making carrier screening essential for accurate reproductive risk assessmen
Find the best DNA test kits from OneDNA for preventive health and personalized care. Start your genetic journey with trusted, expert-backed solutions today now.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of le
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of le
OneDNA delivers advanced genetic testing and genomics solutions, supporting early diagnosis, preventive care, and personalized health insights for outcomes.
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of legacy
OneDNA is committed to making clinically relevant and affordable genomic testing accessible to individuals, clinicians, and healthcare partners across India. Our portfolio spans preventive genomics, pharmacogenomics, clinical genetics, microbiome analysis, maternal screening, and newborn screening, enabling informed health decisions across the life continuum.
Lords Mark Industries, a diversified conglomerate with over 27 years of legacy
OneDNA offers advanced DNA testing & personalized genetic counseling in Hyderabad. Discover your hidden health risks early and act now. Book your test today!
Lords Mark Industries, a diversified conglomerate with over 27 years of legacy and excellence. With a strong presence across sectors including paper, healthcare, biotechnology, solar energy, electric mobility, and more, Lords Mark Industries brings its commitment to innovation and quality to every venture.
To deliver accurate, accessible, and clinically relevant genomic solutions by translating advanced genetic science into actionable
Lords Mark Industries, a diversified conglomerate with over 27 years of legacy and excellence. With a strong presence across sectors including paper, healthcare, biotechnology, solar energy, electric mobility, and more, Lords Mark Industries brings its commitment to innovation and quality to every venture.
To deliver accurate, accessible, and clinically relevant genomic solutions by translating advanced genetic science into actionable